financetom
Business
financetom
/
Business
/
Lyft Launches Rider Verification Pilot Program to Improve Security Measures
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Lyft Launches Rider Verification Pilot Program to Improve Security Measures
Aug 29, 2024 9:15 AM

06:30 AM EDT, 08/28/2024 (MT Newswires) -- Lyft ( LYFT ) on Tuesday said that it is introducing a new rider verification pilot program to help drivers verify riders' identities to improve security measures.

The program has been rolled out in nine cities including Atlanta, Chicago, Denver, Detroit, Houston, Jacksonville, Miami, Phoenix and Seattle.

To verify a rider, the company said it will cross-check personal information, like their legal name and phone number, using trusted, third-party databases. If their information cannot be validated, riders may be asked to upload an ID.

Once verified by Lyft ( LYFT ), riders will be able to see a verification badge next to their profile. Drivers will also be able see the rider's name and verification badge in addition to their rating and photo.

Like riders, drivers will be able to share their location with a friend, connect to live support in the app, and get check-ins if the ride has long stops or route deviations, the company said.

Drivers can still choose to accept rides without badges, however the company warned that these riders may experience longer estimated time of arrival and pickup times.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sinovac Biotech Starts Enrolment in Late-Stage Trial of Investigational Bivalent Vaccine for HFMD
Sinovac Biotech Starts Enrolment in Late-Stage Trial of Investigational Bivalent Vaccine for HFMD
Dec 16, 2024
09:21 AM EST, 12/16/2024 (MT Newswires) -- Sinovac Biotech ( SVA ) said Monday that it has begun enrollment in a late-stage study of its investigational bivalent vaccine targeting Hand, Foot, and Mouth Disease, or HFMD, caused by enterovirus 71 and coxsackievirus 16. The company said the trial will evaluate the potential vaccine's efficacy, safety, and immune response in children...
Shyft to Merge With Aebi Schmidt in All-Stock Deal
Shyft to Merge With Aebi Schmidt in All-Stock Deal
Dec 16, 2024
09:25 AM EST, 12/16/2024 (MT Newswires) -- Shyft ( SHYF ) and Aebi Schmidt said Monday they have agreed to merge in an all-stock deal to create a specialty vehicles company. Under the deal, each outstanding Shyft ( SHYF ) share will be exchanged for 1.04 shares of the combined company's shares, the companies said, adding that Shyft ( SHYF...
Corcept Therapeutics' Phase 3 Study of Relacorilant Shows Improvements in Patients With Hypercortisolism
Corcept Therapeutics' Phase 3 Study of Relacorilant Shows Improvements in Patients With Hypercortisolism
Dec 16, 2024
09:29 AM EST, 12/16/2024 (MT Newswires) -- Corcept Therapeutics ( CORT ) said Monday that results from its phase 3 study of relacorilant to treat patients suffering from endogenous hypercortisolism showed clinically meaningful and durable cardiometabolic improvements. Hypercortisolism, or Cushing's syndrome, occurs when the body produces too much cortisol, which can cause high blood pressure leading to increased cardiovascular risk...
What's Going On With ASP Isotopes Stock Monday?
What's Going On With ASP Isotopes Stock Monday?
Dec 16, 2024
ASP Isotopes Inc ( ASPI ) shares are trading higher. The company on Monday wrote a letter to shareholders, providing a balance sheet update, highlighting progress on goals and announcing an investor access event. What Happened: ASP Isotopes ( ASPI ) chairman and CEO Paul Mann highlighted several milestones for 2024 and set the stage for 2025 in a letter...
Copyright 2023-2026 - www.financetom.com All Rights Reserved